News tagged with biotechnology company
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
Medications May 13, 2013 | not rated yet | 0
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other May 02, 2013 | not rated yet | 0
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Genetics Apr 13, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—The University of Delaware's Prasad Dhurjati is a chemical engineer whose background includes systems engineering, biotechnology and artificial intelligence. Yet recently, he has been investigating autism ...
Autism spectrum disorders Mar 05, 2013 | 2 / 5 (2) | 2
Genetics researchers have identified 25 additional copy number variations (CNVs)—missing or duplicated stretches of DNA—that occur in some patients with autism. These CNVs, say the researchers, are "high impact": although ...
Genetics Jan 14, 2013 | 4.3 / 5 (3) | 0 |
Melbourne researchers have developed cows' milk that protects human cells from HIV.
HIV & AIDS Oct 17, 2012 | not rated yet | 0
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
Immunology Oct 11, 2012 | 5 / 5 (2) | 0 |
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Cancer Oct 01, 2012 | not rated yet | 0
A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally ...
Cardiology Jul 17, 2012 | not rated yet | 0
Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.
Cancer Jan 24, 2012 | not rated yet | 0
A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu ...
Medications Jun 07, 2011 | 5 / 5 (3) | 0 |